ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bullish•Smartkarma
•10 Mar 2018 13:42

Smartkarma: ECM Coverage Weekly Update (10 March 2018)

The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. It has been a busy...

Share
bearish•Celltrion Inc
•07 Mar 2018 05:34

ION's Celltrion Block Deals - Summary & Impacts

Below is a brief summary of this block deal involving ION Investments B.V. (Temasek's subsidiary)'s Celltrion/Celltrion Healthcare stake.As...

Logo
529 Views
Share
bullish•Celltrion Inc
•06 Mar 2018 19:53

Celltrion & Celltrion Healthcare Placement - Spread Should Narrow as Inclusion Draws Closer

Ion Investment (Temasek) is looking to sell its stake in 2.24m and 2.9m shares in Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS)...

Share
bearish•Celltrion Inc
•03 Mar 2018 01:24

Short Selling Viability Assessment on Celltrion After KOSPI 200 Inclusion

Another wonderful day for Celltrion Inc (068270 KS) shareholders, but not a pleasant day for Celltrion short sellers. The shares had a 0.57% gain...

Logo
390 Views
Share
•19 Feb 2018 10:27

Korean IPOs - Evidence-Based Analysis & The Whiplash Effect

In this report, we provide evidence-based analysis of using key criteria such as the IPO price determined at high/low end of the IPO price range...

Logo
302 Views
Share
x